Search research articles
Contact Us
Filters
Showing results (71-80 of 106) with videos related to
Page
of 11
Sort By:
Dermatology and Therapy
|
December 30, 2022
Real-World Findings on the Characteristics and Treatment Exposures of Patients with Hidradenitis Suppurativa from US Claims Data
Amit Garg, Haley B Naik, Afsaneh Alavi, et al.
Skin Appendage Disorders
|
August 18, 2022
Guidance on COVID-19 Vaccination in Hidradenitis Suppurativa Patients: A Modified Delphi Consensus of Experts
Jonathan W Rick, Devea R De, Terri Shih, et al.
Biorxiv : the Preprint Server for Biology
|
March 9, 2026
Computational discovery of precision therapeutics for hidradenitis suppurativa
Ernest Y Lee, Phoebe Leboit, Haley B Naik, et al.
Journal of the American Academy of Dermatology
|
September 19, 2021
Biologic therapy is not associated with increased COVID-19 severity in patients with hidradenitis suppurativa: Initial findings from the Global Hidradenitis Suppurativa COVID-19 Registry
Haley B Naik, Raed Alhusayen, John Frew, et al.
Dermatology (Basel, Switzerland)
|
December 25, 2022
Biologic Therapy Is Not Associated with Increased COVID-19 Severity in Patients with Hidradenitis Suppurativa: Updated Findings from the Global Hidradenitis Suppurativa COVID-19 Registry
Jazzmin C Williams, Raed Alhusayen, Sandra Guilbault, et al.
American Journal of Clinical Dermatology
|
March 10, 2026
Defining Moderate Disease and Progression in Hidradenitis Suppurativa: An Expert Framework to Unlock the Window of Opportunity for Prompt Treatment
Antonio Martorell, John R Ingram, Christopher J Sayed, et al.
American Journal of Hematology
|
November 4, 2014
Clinical significance of autoantibodies in a large cohort of patients with chronic graft-versus-host disease defined by NIH criteria
Zoya Kuzmina, Verena Gounden, Lauren Curtis, et al.
Journal of the American Academy of Dermatology
|
February 10, 2025
Patients with PSOriasis and Suppurative Hidradenitis (PSO-SH) share genetic risk factors and are at risk of increased morbidity
Antonia Wiala, Kareem G Elhage, Andrea Leung, et al.
Biorxiv : the Preprint Server for Biology
|
February 24, 2023
Tertiary Lymphoid Structures Sustain Cutaneous B cell Activity in Hidradenitis Suppurativa
Margaret M Lowe, Jarish N Cohen, Madison I Moss, et al.
JCI Insight
|
August 26, 2020
Immunopathogenesis of hidradenitis suppurativa and response to anti-TNF-α therapy
Margaret M Lowe, Haley B Naik, Sean Clancy, et al.
Page
of 11
Search research articles
Search
Showing results (71-80 of 106) with videos related to
Sort By:
Page
of 11
Dermatology and Therapy
|
December 30, 2022
Real-World Findings on the Characteristics and Treatment Exposures of Patients with Hidradenitis Suppurativa from US Claims Data
Amit Garg, Haley B Naik, Afsaneh Alavi, et al.
Skin Appendage Disorders
|
August 18, 2022
Guidance on COVID-19 Vaccination in Hidradenitis Suppurativa Patients: A Modified Delphi Consensus of Experts
Jonathan W Rick, Devea R De, Terri Shih, et al.
Biorxiv : the Preprint Server for Biology
|
March 9, 2026
Computational discovery of precision therapeutics for hidradenitis suppurativa
Ernest Y Lee, Phoebe Leboit, Haley B Naik, et al.
Journal of the American Academy of Dermatology
|
September 19, 2021
Biologic therapy is not associated with increased COVID-19 severity in patients with hidradenitis suppurativa: Initial findings from the Global Hidradenitis Suppurativa COVID-19 Registry
Haley B Naik, Raed Alhusayen, John Frew, et al.
Dermatology (Basel, Switzerland)
|
December 25, 2022
Biologic Therapy Is Not Associated with Increased COVID-19 Severity in Patients with Hidradenitis Suppurativa: Updated Findings from the Global Hidradenitis Suppurativa COVID-19 Registry
Jazzmin C Williams, Raed Alhusayen, Sandra Guilbault, et al.
American Journal of Clinical Dermatology
|
March 10, 2026
Defining Moderate Disease and Progression in Hidradenitis Suppurativa: An Expert Framework to Unlock the Window of Opportunity for Prompt Treatment
Antonio Martorell, John R Ingram, Christopher J Sayed, et al.
American Journal of Hematology
|
November 4, 2014
Clinical significance of autoantibodies in a large cohort of patients with chronic graft-versus-host disease defined by NIH criteria
Zoya Kuzmina, Verena Gounden, Lauren Curtis, et al.
Journal of the American Academy of Dermatology
|
February 10, 2025
Patients with PSOriasis and Suppurative Hidradenitis (PSO-SH) share genetic risk factors and are at risk of increased morbidity
Antonia Wiala, Kareem G Elhage, Andrea Leung, et al.
Biorxiv : the Preprint Server for Biology
|
February 24, 2023
Tertiary Lymphoid Structures Sustain Cutaneous B cell Activity in Hidradenitis Suppurativa
Margaret M Lowe, Jarish N Cohen, Madison I Moss, et al.
JCI Insight
|
August 26, 2020
Immunopathogenesis of hidradenitis suppurativa and response to anti-TNF-α therapy
Margaret M Lowe, Haley B Naik, Sean Clancy, et al.
Page
of 11